The North America cardiovascular ultrasound market is expected to project a CAGR of 5.17% during the forecast period, 2022-2030, and is estimated to reach revenue of $671.63 million by 2030.

The region has the presence of several key players, which boosts the cardiovascular ultrasound market growth prospects. Additionally, the high adoption of ultrasound modality in general diagnostics and the surging lifestyle-related chronic diseases contribute to market growth. According to the American Heart Association, heart disease is the leading cause of death in the United States, constituting 14% of the total deaths. However, the market growth is hindered by the lack of awareness and knowledge regarding cardiovascular problems and treatment methods.

To know more about this report, request a free sample copy

The North America cardiovascular ultrasound market growth evaluation includes the analysis of the United States and Canada. In the United States, cardiovascular diseases like heart attack, stroke, and heart disease are among the common death causes. Also, the shifting lifestyle patterns have made the population increasingly vulnerable to cardiovascular diseases. According to CDC, in 2020, around 697,000 died from heart disease. In addition, it incurred around $229 billion in expenses during 2017-18. The expenses included lost productivity and the cost of medicines and healthcare services. Accordingly, favorable initiatives are in place to spread awareness about the diseases.

Furthermore, high blood pressure, also termed hypertension, can lead to heart attack, stroke, and heart failure. As per the American Heart Association’s ‘Heart Disease and Stroke Statistics – 2019 Update,’ there have been constant efforts to increase the awareness of high blood pressure levels. This is because cardiovascular disease rise is defined by the changes associated with blood pressure levels.

The North America cardiovascular ultrasound market segmentation includes end-user, display, type, and technology. The end-user segment includes ambulatory care centers, hospitals, diagnostic centers, and other end-users.

Ambulatory care centers are outpatient care centers. They offer several facilities like rehab visits, treatments, and diagnostic tests. There are varied types of outpatient care like x-rays, chemotherapy, blood tests, and ultrasound imaging. Also, the usage and scope of ambulatory care centers have increased over time. They do not need patients’ overnight stay in the hospitals.

Additionally, surgeries and procedures are performed in ambulatory care centers since they employ the same professionals as the hospitals. These include medical administrative staff, medical lab technicians, surgical technicians, physical therapists, registered nurses, doctors, etc. Accordingly, ambulatory care centers are the fastest-growing end-user in the cardiovascular ultrasound market.

On the other hand, hospitals are the major revenue-generating end-user in the cardiovascular ultrasound market. Most echocardiography types are used in hospitals since hospitals are prime locations accessible to patients. Also, transthoracic echocardiography is the primary type used in hospitals for patients with acute cerebrovascular disease and acute myocardial infarction, followed by fetal echocardiography and transesophageal echocardiography. Moreover, surgeons and doctors in hospitals use echocardiography to assess problems related to the heart and signs of heart disease like poor functioning of heart valves, blood clots, and weak heart muscle.

Some of the prominent firms operating in the North America cardiovascular ultrasound market include GE Healthcare, Lanmage, Fujifilm Holdings Corporation, Esaote SpA, Dawei Medical, etc.

GE Healthcare is a leading global pharmaceutical diagnostic, digital solutions, and medical technology innovator. The company’s products facilitate more informed and faster decisions for clinicians through applications & services, data analytics, and intelligent devices, supplemented by its Edison intelligence platform. It provides products and services like patient monitoring, diagnostics ECGA, imaging, ultrasound, etc. The company is present in over 160 countries, covering Asia-Pacific, Latin America, and North America, with headquarters in Chicago, the United States.

One of its key products, Vivid™ Ultra Edition, is a comprehensive portfolio of cardiovascular ultrasound systems that enable clinical excellence with advancements in automation, quantification, navigation, and visualization.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.